{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T09:07:24Z","timestamp":1719738444113},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Meat Research Corporation of Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Cell Biol"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:p>In the present study we have investigated the use of recombinant ovine IL\u20101\u03b2 and TNF\u2010\u03b1 both alone and in combination, as natural adjuvants in vaccination trials in sheep. Initial experiments were conducted to investigate the physiological effects of the cytokines <jats:italic>in vivo<\/jats:italic> and determine what dose could be administered without adverse pyrogenic effects. Even at the maximum dose tested (100 \u03bcg) the only significant physiological effect was a transient increase in body temperature of approximately 2\u00b0C in sheep injected with TNF\u2010\u03b1. Administration of either cytokine had profound effects on the levels of circulating leucocytes for up to 5 days postinjection. The incorporation of either IL\u20101\u03b2 or TNF\u2010\u03b1 in aqueous or Al(OH)<jats:sub>3<\/jats:sub> vaccine formulations enhanced antibody responses to a recombinant antigen from the cestode parasite <jats:italic>Taenia ovis<\/jats:italic>. The addition of IL\u20101\u03b2 to aqueous vaccine formulations increased antibody responses 15\u201320\u2010fold and in Al(OH)<jats:sub>3<\/jats:sub> formulations by three to six fold. TNF\u2010\u03b1 stimulated 1.5 to six\u2010fold and 2.5 to seven\u2010fold increases in antibody levels in aqueous and Al(OH)<jats:sub>3<\/jats:sub>\u2010based formulations, respectively, in a dose\u2010dependent manner. The addition of either cytokine to Quil A or IFA vaccines did not enhance the antibody levels elicited. When 10 \u03bcg of both IL\u20101\u03b2 and TNF\u2010\u03b1 were incorporated in the aqueous or Al(OH)<jats:sub>3<\/jats:sub> vaccine formulations, increases of 21\u2010fold and 25\u2010fold, respectively, were observed in antibody levels. The adjuvant activity of IL\u20101\u03b2 and TNF\u2010\u03b1 in combination in the Al(OH)<jats:sub>3<\/jats:sub>\u2010based vaccine resulted in antibody levels commensurate with those obtained using Quil A or IFA.<\/jats:p>","DOI":"10.1046\/j.1440-1711.1998.00729.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:40:05Z","timestamp":1047429605000},"page":"167-172","source":"Crossref","is-referenced-by-count":17,"title":["The use of recombinant ovine IL\u20101\u03b2 and TNF\u2010\u03b1 as natural adjuvants and their physiological effects <i>in vivo<\/i>"],"prefix":"10.1111","volume":"76","author":[{"given":"JS","family":"Rothel","sequence":"first","affiliation":[{"name":"The University of Melbourne, Molecular Parasitology Laboratory, Veterinary Clinical Centre  Werribee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u2010F","family":"Seow","sequence":"additional","affiliation":[{"name":"CSIRO Division of Animal Health  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MW","family":"Lightowlers","sequence":"additional","affiliation":[{"name":"The University of Melbourne, Molecular Parasitology Laboratory, Veterinary Clinical Centre  Werribee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BW","family":"Parry","sequence":"additional","affiliation":[{"name":"The University of Melbourne, Molecular Parasitology Laboratory, Veterinary Clinical Centre  Werribee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Gauci","sequence":"additional","affiliation":[{"name":"The University of Melbourne, Molecular Parasitology Laboratory, Veterinary Clinical Centre  Werribee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Hurst","sequence":"additional","affiliation":[{"name":"CSIRO Division of Animal Health  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u2010J","family":"Mucha","sequence":"additional","affiliation":[{"name":"CSIRO Division of Animal Health  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LA","family":"Corner","sequence":"additional","affiliation":[{"name":"CSIRO Division of Animal Health  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PR","family":"Wood","sequence":"additional","affiliation":[{"name":"CSIRO Division of Animal Health  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1998,4]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"49","volume-title":"Animal Parasite Control Utilizing Biotechnology","author":"Cox JC","year":"1992"},{"key":"e_1_2_7_3_1","first-page":"1339","article-title":"Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases.","volume":"21","author":"Lin R","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"e_1_2_7_4_1","first-page":"1","volume-title":"Progress in Vaccinology. 4. Veterinary Vaccines","author":"East IJ","year":"1993"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90149-2"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/3.3.229"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90083-J"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90318-F"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90389-2"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01878491"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/978-1-4615-1823-5_27","volume-title":"Vaccine Design: The Subunit and Adjuvant Approach","author":"Dong P","year":"1995"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/978-1-4615-1823-5_28","volume-title":"Vaccine Design: The Subunit and Adjuvant Approach","author":"Heath AW","year":"1995"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/338585a0"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(94)90099-X"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(94)05305-C"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/15321818108056977"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.139.3.800","article-title":"In vivo immunostimulating activity of the 163\u2013171 peptide of human IL\u20101\u03b2.","volume":"139","author":"Nencioni L","year":"1987","journal-title":"J. Immunol."},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1152\/jappl.1992.73.5.1831","article-title":"Plasma tumor necrosis factor\u2010alpha during long term endotoxemia in awake sheep.","volume":"75","author":"Sloane PJ","year":"1992","journal-title":"J. Appl. Physiol."},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00074-B"},{"key":"e_1_2_7_20_1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1152\/jappl.1989.66.3.1448","article-title":"Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep.","volume":"66","author":"Johnson J","year":"1989","journal-title":"J. Appl. Physiol."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.10.040192.002211"},{"key":"e_1_2_7_22_1","first-page":"295","article-title":"Adjuvanticity of recombinant bovine interleukin\u20101\u03b2: Influence on immunity, infection, and latency in a bovine herpesvirus\u20101 infection.","volume":"9","author":"Reddy DN","year":"1990","journal-title":"Lymphokine Res."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(93)90013-T"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90005-1"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1993.43"},{"key":"e_1_2_7_26_1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0264-410X(94)00053-P","article-title":"Humoral and cellular responses induced by intradermally administered cytokine and conventional adjuvants.","volume":"13","author":"Lofthouse SA","year":"1995","journal-title":"Vaccine"},{"key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.4049\/jimmunol.139.11.3676","article-title":"Enhancement of in vivo immune response by tumor necrosis factor.","volume":"139","author":"Ghiara P","year":"1987","journal-title":"J. Immunol."},{"key":"e_1_2_7_28_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1099\/0022-1317-75-1-55","article-title":"Modulation of antiviral immune responses by exogenous cytokines: Effects of tumour necrosis factor\u2010\u03b1, interleukin\u20101\u03b2, interleukin\u20102 and interferon\u2010\u03b3 on the immunogenicity of an inactivated rabies vaccine.","volume":"75","author":"Schijns VECJ","year":"1994","journal-title":"J. Gen. Virol."},{"key":"e_1_2_7_29_1","first-page":"251","article-title":"A limited role of IL\u20101 in immune\u2010enhancement by adjuvants.","volume":"71","author":"Sagara T","year":"1990","journal-title":"Immunology"}],"container-title":["Immunology &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1711.1998.00729.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1711.1998.00729.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T01:38:52Z","timestamp":1695951532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1711.1998.00729.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1046\/j.1440-1711.1998.00729.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1711.1998.00729.x","archive":["Portico"],"relation":{},"ISSN":["0818-9641","1440-1711"],"issn-type":[{"value":"0818-9641","type":"print"},{"value":"1440-1711","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}